LORAZEPAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lorazepam, and what generic alternatives are available?
Lorazepam is a drug marketed by Amneal Pharms, Chartwell Molecular, Hikma, Lupin Ltd, Pharm Assoc, Bedford, Dr Reddys, Endo Operations, Epic Pharma Llc, Hospira, Intl Medication Sys, Rising, Watson Labs, Roxane, Am Therap, Anda Repository, Ani Pharms, Aurolife Pharma Llc, Chartwell Rx, Halsey, Leading, Mutual Pharm, Oxford Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Warner Chilcott, and Bedford Labs. and is included in sixty-four NDAs.
The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lorazepam
A generic version of LORAZEPAM was approved as lorazepam by SANDOZ on April 21st, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LORAZEPAM?
- What are the global sales for LORAZEPAM?
- What is Average Wholesale Price for LORAZEPAM?
Summary for LORAZEPAM
| US Patents: | 0 |
| Applicants: | 30 |
| NDAs: | 64 |
| Finished Product Suppliers / Packagers: | 33 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Clinical Trials: | 198 |
| Patent Applications: | 4,340 |
| Drug Prices: | Drug price information for LORAZEPAM |
| Drug Sales Revenues: | Drug sales revenues for LORAZEPAM |
| What excipients (inactive ingredients) are in LORAZEPAM? | LORAZEPAM excipients list |
| DailyMed Link: | LORAZEPAM at DailyMed |
Recent Clinical Trials for LORAZEPAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Laureate Institute for Brain Research, Inc. | Phase 4 |
| California Institute of Technology | Phase 4 |
| Temple University | Phase 4 |
Pharmacology for LORAZEPAM
| Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for LORAZEPAM
Anatomical Therapeutic Chemical (ATC) Classes for LORAZEPAM
US Patents and Regulatory Information for LORAZEPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | LORAZEPAM | lorazepam | TABLET;ORAL | 071193-001 | Apr 15, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Anda Repository | LORAZEPAM | lorazepam | TABLET;ORAL | 072555-002 | Mar 29, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | LORAZEPAM | lorazepam | INJECTABLE;INJECTION | 074276-001 | Apr 15, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Warner Chilcott | LORAZEPAM | lorazepam | TABLET;ORAL | 071039-001 | Jan 12, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
